View drug registration information details.

Items	Registration information
ID	642
No	642
Brand Name	YANCI-20
Ingredients	DROSPIRENONE PH.EUR 3 MG, ETHINYLESTRADILOL PH.EUR 0.02 MG
Dosage Form	TABLET
Primary Packaging	ALU-PVDC/PVC BLISTER
Storage	STORE BELOW 30 C
Shelf Life	2 YEARS
Pack Size	BLISTERPACK OF 28 TABLETS ( 24 TABLETS DROSPIRENONE 3 MG AND ETHINYLESTRADIOL 0.02 MG, 4 INERT TABLETS)
Dispensing Category	PRESCRIPTION
ATC Classification	G03AA12
Pharmaceutical Class	PROGESTOGEN AND ESTROGEN
Indications	ORAL CONTRACEPTION
Contraindications	COMBINED HORMONAL CONTRACEPTIVES, PRESENCE OR RISK OF VENOUS THROMBOEMBOLISM, PRESENSE OR IRSK OF ARTERIAL THROMBOEMBOLISM, PRESENCE OR HISTORY OF SEVERE HEPATIC DISEASE, RENAL INSUFFICIENCY OR ACUTE RENAL FSILURE
Side Effects	EMOTIONAL LABILITY, HEADACHE, NAUSEA, BREAST PAIN, AMENORRHEA, METRORRHAGIA
Unit Price
EDL	No
Description	ROUND, LIGHT YELLOW, UNCOATED BICONVEX TABLETS WITH "144" DEBOSSED ON ONE SIDE AND OTHER SIDE PLAIN
Note
License Owner	DKSH LAOS COMPANY LIMITED
Manufacturer	MYLAN LABORATORIES LIMITED
Country	INDIA
Import Registration No	G/28/1297
Import Registration Date	2016-11-04
Activity	CERTIFICATE RELEASED
Applied Date	2021-12-03
FDD Registration No	04 I 5468/23
FDD Registration Date	2023-04-11
Expiry Date	2026-04-10

Back to drug list